One aspect of the present invention relates to diazabicyclo[4.3.0]nonanes. A second aspect of the present invention relates to the use of the diazabicyclo[4.3.0]nonanes as ligands for various cellular receptors, including opiate receptors. An additional aspect of the present invention relates to the use of the diazabicyclo[4.3.0]nonanes as analgesics.

 
Web www.patentalert.com

< (none)

< Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations

> Clock gene and methods of use thereof

> (none)
~ 00050